Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07838740 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Phase 1 Study of VK2735 in Obese Adults Without Comorbidities

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The goal of this Phase 1, randomized, double-blind, placebo-controlled study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of VK2735 in adults who are obese (BMI ≥ 30 kg/m2) without comorbidities.
Trial Details
NCT Number NCT07838740
Lead Sponsor Viking Therapeutics, Inc.
Conditions
(from sponsor)		 Obese Adults
Related terms Weight Loss
Enrollment 270 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov